论文部分内容阅读
目的:探讨肝动脉灌注化疗并栓塞(TACE)结合部分性脾动脉栓塞(PASE)治疗原发性肝癌合并脾功能亢进的应用价值。材料与方法:对36例中晚期肝癌病人在进行肝动脉灌注化疗栓塞的同时进行部分性脾动脉栓塞治疗,观察病人白细胞、血小板计数、肝功能的变化、肿瘤缩小等情况和术后反应,判断治疗效果。结果:所有病人治疗后白细胞和血小板计数升高,肝功能恢复快,术后1个月临床症状改善,肿瘤体积有不同程度缩小,无严重并发症发生。结论:TACE和PASE是治疗原发性肝癌合并脾功能亢进安全、有效的方法。有助于改善患者肝功能,缓减脾功能亢进,促使白细胞、血小板升高,为肝癌介入治疗的顺利进行创造条件。
Objective: To investigate the clinical value of transcatheter arterial chemoembolization (TACE) combined with partial septal arterial embolism (PASE) in the treatment of primary hepatocellular carcinoma complicated with hypersplenism. Materials and Methods: Thirty-six patients with advanced hepatocellular carcinoma undergoing partial hepatic arterial chemoembolization were treated with partial splenic arterial embolization. The patients’ white blood cell count, platelet count, liver function, tumor shrinkage and postoperative reaction were observed and judged treatment effect. Results: After treatment, the leucocyte and platelet count increased, the liver function recovered rapidly, the clinical symptoms improved at one month after operation, and the tumor volume decreased to some extent without serious complication. Conclusion: TACE and PASE are safe and effective in treating primary hepatocellular carcinoma complicated with hypersplenism. Help to improve liver function, reduce hypersplenism, and to promote leukocytes, platelets, for the successful intervention of liver cancer to create the conditions.